Loading comparison data...
Medical Disclaimer: This site provides informational comparisons only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before making medication decisions.
Compare ALIROCUMAB (Praluent) and EZETIMIBE (EZETIMIBE) — clinical data, side effects, and patient experiences.
Praluent · PCSK9 Inhibitor
How it works
12.1 Mechanism of Action Alirocumab is a human monoclonal antibody that binds to proprotein convertase subtilisin kexin type 9 (PCSK9). PCSK9 binds to the low-density lipoprotein (...
Approved for
EZETIMIBE, Zetia · Cholesterol Absorption Inhibitor
How it works
12.1 Mechanism of Action Ezetimibe reduces blood cholesterol by inhibiting the absorption of cholesterol by the small intestine. The molecular target of ezetimibe has been shown to...
Approved for
Estimated frequency (%) based on clinical trial data
Based on 11 Reddit discussions
ALIROCUMAB
0%
positive
8 threads
EZETIMIBE
33%
positive
3 threads
% of discussions mentioning each side effect
8 Reddit threads analysed for ALIROCUMAB
Overall Sentiment
Mixed
Comparison Threads
5
Avg Post Score
5 upvotes
Most discussed side effects in community
Threads directly comparing ALIROCUMAB to other medications
#111 Clinical Trials updated on 2021-07-28 All 111 studies in this list are **actively recruiting** at one or more locations. Most studies in this list **accept healthy volunteers** with the exception of any studies missing a 'Y' in the Healthy Volunteers column. Those studies may or may not be ac
#102 Clinical Trials updated on 2021-07-27 All 102 studies in this list are **actively recruiting** at one or more locations. Most studies in this list **accept healthy volunteers** with the exception of any studies missing a 'Y' in the Healthy Volunteers column. Those studies may or may not be ac
#54 Clinical Trials updated on 2021-07-19 All 54 studies in this list are **actively recruiting** at one or more locations. Most studies in this list **accept healthy volunteers** with the exception of any studies missing a 'Y' in the Healthy Volunteers column. Those studies may or may not be acce
#136 Clinical Trials updated on 2021-07-23 All 136 studies in this list are **actively recruiting** at one or more locations. Most studies in this list **accept healthy volunteers** with the exception of any studies missing a 'Y' in the Healthy Volunteers column. Those studies may or may not be ac
#74 Clinical Trials updated on 2021-07-22 All 74 studies in this list are **actively recruiting** at one or more locations. Most studies in this list **accept healthy volunteers** with the exception of any studies missing a 'Y' in the Healthy Volunteers column. Those studies may or may not be acce
Here are the links to the two abstracts in NEJM: [Alirocumab abstract](http://www.nejm.org/doi/full/10.1056/NEJMoa1501031) [Evolocumab abstract](http://www.nejm.org/doi/full/10.1056/NEJMoa1500858) I saw the evolocumab story on NBC Nightly News last night, and you know if I saw it, thousands upon tho
Does anyone know of any studied benefit in switching between evolocumab and alirocumab? If you’ve heard of/read any articles, please point me in that direction as well. TIA
# Enlicitid: Erster oraler PCSK9-Inhibitor – Game-Changer für Cholesterin-Therapie? Auf der AHA-Jahrestagung in New Orleans wurden gerade die Phase-3-Daten zu **Enlicitid (Enlicitide Decanoate, MK-0616)** von Merck/MSD vorgestellt. Falls ihr es nicht mitbekommen habt: Das könnte ein ziemlicher Durch
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
3 Reddit threads analysed for EZETIMIBE
Overall Sentiment
Mixed
Comparison Threads
1
Avg Post Score
6 upvotes
Threads directly comparing EZETIMIBE to other medications
A lot of people feel it either goes one way or the other. Strong feelings in cardiology toward one or the other, but maybe they aren't mutually exclusive theories... How do you feel as a pharmacist? Are you cool seeing patients on statin + ezetimibe in primary prevention? Okay with patients on ezet
Hello, I work in Italy and recently I see more and more patients that are prescribed to start therapy for high cholesterol with the combination statin + ezetimibe. When I studied, I was tought to use maximally tollerated statin dose and then add ezetimibe if necessary. The latest guideline I found i
When you have to pack combo-pack meds (eg. rosuvastatin / ezetimibe (Rosuzet/ Ezalo) where the pack is two separate tablets daily instead of a single tablet with both medications, what is your preferred method for charting in the software? Both seem very imperfect and cause confusion with my patient
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
ALIROCUMAB is a PCSK9 Inhibitor, while EZETIMIBE belongs to the Cholesterol Absorption Inhibitor class. This means they work through different pharmacological mechanisms, which may influence both efficacy and side effect profiles. ALIROCUMAB is administered via Subcutaneous, whereas EZETIMIBE uses Oral. Route of administration can affect onset of action and patient adherence.
ALIROCUMAB carries 4 FDA warnings. EZETIMIBE carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.